Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study

Shai Levi; Yotam Bronstein; Neta Goldschmidt; Fortunato Morabito; Francesco Morabito; Tomer Ziv-Baran; Giovanni Del Poeta; Osnat Bairey; Maria Ilaria Del Principe; Riva Fineman; Francesca Romana Mauro; Odit Gutwein; Gianluigi Reda; Rosa Ruchlemer; Paolo Sportoletti; Luca Laurenti; Lev Shvidel; Marta Coscia; Tamar Tadmor; Marzia Varettoni; Ariel Aviv; Roberta Murru; Andrei Braester; Annalisa Chiarenza; Andrea Visentin; Daniela Pietrasanta; Giacomo Loseto; Antonella Zucchetto; Riccardo Bomben; Jacopo Olivieri; Antonio Neri; Davide Rossi; Dario Rossi; Gianluca Gaidano; Livio Trentin; Robin Foà; Robin Foa; Antonio Cuneo; Chava Perry; Valter Gattei; Massimo Gentile; Yair Herishanu

doi:10.1002/ajh.26779

Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study

Shai Levi
, Yotam Bronstein
, Neta Goldschmidt
, Fortunato Morabito
, Francesco Morabito
, Tomer Ziv-Baran
, Giovanni Del Poeta
, Osnat Bairey
, Maria Ilaria Del Principe
, Riva Fineman
, Francesca Romana Mauro
, Odit Gutwein
, Gianluigi Reda
, Rosa Ruchlemer
, Paolo Sportoletti
, Luca Laurenti
, Lev Shvidel
, Marta Coscia
, Tamar Tadmor
, Marzia Varettoni

Ariel Aviv, Roberta Murru, Andrei Braester, Annalisa Chiarenza, Andrea Visentin, Daniela Pietrasanta, Giacomo Loseto, Antonella Zucchetto, Riccardo Bomben, Jacopo Olivieri, Antonio Neri, Davide Rossi, Dario Rossi, Gianluca Gaidano, Livio Trentin, Robin Foà, Robin Foa, Antonio Cuneo, Chava Perry, Valter Gattei, Massimo Gentile, Yair Herishanu

Tel Aviv Sourasky Medical Center
Hadassah University Medical Centre
Hematology Unit AO of Cosenza
Tel Aviv University
University of Rome Tor Vergata
Rabin Medical Center Israel
Rambam Health Care Campus Israel
University “La Sapienza” of Rome
Assaf Harofeh Medical Center
IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
Shaare Zedek Medical Center
University of Perugia
Kaplan Medical Center Israel
Azienda Ospedaliera - Universitaria Città della Salute e della Scienza di Torino
Bnai-Zion Medical Center
IRCCS Fondazione Policlinico San Matteo - Pavia
Emek Medical Center
AO Brotzu
Western Galilee Medical Center of Nahariya
University of Catania
University of Padua
Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo
IRCCS Istituto tumori Giovanni Paolo II - Bari
IRCCS Centro di Riferimento Oncologico - Aviano PN
Integrata
IRCCS Azienda Unità Sanitaria Locale di Reggio Emilia
Oncology Institute of Southern Switzerland (IOSI)
University of Eastern Piedmont
University of Ferrara

Risultato della ricerca: Contributo in rivista › Articolo

Lingua originale	Inglese
pagine (da-a)	E24-E27
Rivista	American Journal of Hematology
Volume	98
DOI	https://doi.org/10.1002/ajh.26779
Stato di pubblicazione	Pubblicato - 2023

Keywords

Ibrutinib

Accesso al documento

10.1002/ajh.26779

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Levi, S., Bronstein, Y., Goldschmidt, N., Morabito, F., Morabito, F., Ziv-Baran, T., Del Poeta, G., Bairey, O., Del Principe, M. I., Fineman, R., Mauro, F. R., Gutwein, O., Reda, G., Ruchlemer, R., Sportoletti, P., Laurenti, L., Shvidel, L., Coscia, M., Tadmor, T., ... Herishanu, Y. (2023). Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study. American Journal of Hematology, 98, E24-E27. https://doi.org/10.1002/ajh.26779

@article{44d6c65cd8e3420bb7fb31ab2b1cbf10,

title = "Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study",

keywords = "Ibrutinib, Ibrutinib",

author = "Shai Levi and Yotam Bronstein and Neta Goldschmidt and Fortunato Morabito and Francesco Morabito and Tomer Ziv-Baran and \{Del Poeta\}, Giovanni and Osnat Bairey and \{Del Principe\}, \{Maria Ilaria\} and Riva Fineman and Mauro, \{Francesca Romana\} and Odit Gutwein and Gianluigi Reda and Rosa Ruchlemer and Paolo Sportoletti and Luca Laurenti and Lev Shvidel and Marta Coscia and Tamar Tadmor and Marzia Varettoni and Ariel Aviv and Roberta Murru and Andrei Braester and Annalisa Chiarenza and Andrea Visentin and Daniela Pietrasanta and Giacomo Loseto and Antonella Zucchetto and Riccardo Bomben and Jacopo Olivieri and Antonio Neri and Davide Rossi and Dario Rossi and Gianluca Gaidano and Livio Trentin and Robin Fo{\`a} and Robin Foa and Antonio Cuneo and Chava Perry and Valter Gattei and Massimo Gentile and Yair Herishanu",

year = "2023",

doi = "10.1002/ajh.26779",

language = "English",

volume = "98",

pages = "E24--E27",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc.",

}

Levi, S, Bronstein, Y, Goldschmidt, N, Morabito, F, Morabito, F, Ziv-Baran, T, Del Poeta, G, Bairey, O, Del Principe, MI, Fineman, R, Mauro, FR, Gutwein, O, Reda, G, Ruchlemer, R, Sportoletti, P, Laurenti, L, Shvidel, L, Coscia, M, Tadmor, T, Varettoni, M, Aviv, A, Murru, R, Braester, A, Chiarenza, A, Visentin, A, Pietrasanta, D, Loseto, G, Zucchetto, A, Bomben, R, Olivieri, J, Neri, A, Rossi, D, Rossi, D, Gaidano, G, Trentin, L, Foà, R, Foa, R, Cuneo, A, Perry, C, Gattei, V, Gentile, M & Herishanu, Y 2023, 'Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study', American Journal of Hematology, vol. 98, pagg. E24-E27. https://doi.org/10.1002/ajh.26779

TY - JOUR

T1 - Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study

AU - Levi, Shai

AU - Bronstein, Yotam

AU - Goldschmidt, Neta

AU - Morabito, Fortunato

AU - Morabito, Francesco

AU - Ziv-Baran, Tomer

AU - Del Poeta, Giovanni

AU - Bairey, Osnat

AU - Del Principe, Maria Ilaria

AU - Fineman, Riva

AU - Mauro, Francesca Romana

AU - Gutwein, Odit

AU - Reda, Gianluigi

AU - Ruchlemer, Rosa

AU - Sportoletti, Paolo

AU - Laurenti, Luca

AU - Shvidel, Lev

AU - Coscia, Marta

AU - Tadmor, Tamar

AU - Varettoni, Marzia

AU - Aviv, Ariel

AU - Murru, Roberta

AU - Braester, Andrei

AU - Chiarenza, Annalisa

AU - Visentin, Andrea

AU - Pietrasanta, Daniela

AU - Loseto, Giacomo

AU - Zucchetto, Antonella

AU - Bomben, Riccardo

AU - Olivieri, Jacopo

AU - Neri, Antonio

AU - Rossi, Davide

AU - Rossi, Dario

AU - Gaidano, Gianluca

AU - Trentin, Livio

AU - Foà, Robin

AU - Foa, Robin

AU - Cuneo, Antonio

AU - Perry, Chava

AU - Gattei, Valter

AU - Gentile, Massimo

AU - Herishanu, Yair

PY - 2023

Y1 - 2023

KW - Ibrutinib

UR - http://hdl.handle.net/10807/235640

U2 - 10.1002/ajh.26779

DO - 10.1002/ajh.26779

M3 - Article

SN - 0361-8609

VL - 98

SP - E24-E27

JO - American Journal of Hematology

JF - American Journal of Hematology

ER -